Evidence map›Paper›PMID 33548053›Full record

ArticleJournal of nephrology2021

COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist.

Timothée Laboux, Jean-Baptiste Gibier, Nicolas Pottier, François Glowacki, Aghilès Hamroun

Erratum issuedAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Overview of acute kidney manifestations and management of patients with COVID-19.American journal of physiology. Renal physiology · 2021
    Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Timothée LabouxKidney Transplantation and Dialysis Department, University of Lille, CHU Lille, 59037, Lille, France. tlaboux@gmail.com.
Jean-Baptiste GibierDepartment of Pathology, Pathology Institute, Lille University, Regional and University Hospital Center of Lille, Lille, France.
Nicolas PottierToxicology and Genopathy Department, CHU Lille, 59000, Lille, France.
François GlowackiKidney Transplantation and Dialysis Department, University of Lille, CHU Lille, 59037, Lille, France.
Aghilès HamrounKidney Transplantation and Dialysis Department, University of Lille, CHU Lille, 59037, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Apolipoprotein L1BiomarkersCOVID-19Glomerulosclerosis, Focal SegmentalHumansKidney GlomerulusMaleMiddle AgedNephrologistsPandemicsRisk FactorsSARS-CoV-2APOL1 protein, humanApolipoprotein L1BiomarkersAPOL1 risk variantCollapsing glomerulopathyCOVID-19-associated nephropathyFSGSSARS-CoV-2

Identifiers

PMID33548053
PMCPMC7865108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.